Influence of corticosteroids on interleukin-1β-stimulated equine chondrocyte gene expression.
Authors: Caron John P, Gandy Jeff C, Schmidt Michelle, Hauptman Joseph G, Sordillo Lorraine M
Journal: Veterinary surgery : VS
Summary
# Editorial Summary: Corticosteroid Effects on Inflammatory Chondrocyte Gene Expression When interleukin-1β triggers inflammatory cascades in articular cartilage—mimicking osteoarthritic processes—intra-articular corticosteroid injections are thought to provide therapeutic benefit, yet direct comparisons between commonly used agents remain limited in equine models. Researchers cultured cartilage explants from young horses and exposed them to recombinant IL-1β whilst treating samples with either triamcinolone acetonide or methylprednisolone acetate at physiologically relevant concentrations, measuring gene expression changes across anabolic markers (aggrecan, collagen II, TIMP enzymes) and catabolic markers (MMP-13, aggrecanase, COX-2) over 6 and 12 hours using quantitative PCR. Both corticosteroids effectively suppressed the IL-1β-induced upregulation of MMP-13 and COX-2, whilst simultaneously restoring TIMP-2 expression—all changes consistent with reduced cartilage breakdown—though MPA showed slightly faster inhibition of MMP-13 at lower concentrations. Critically, no meaningful differences emerged between the two agents across any measured genes, suggesting their divergent clinical outcomes (if observed) likely stem from pharmacokinetic differences, synovial residence times, or post-translational regulatory mechanisms rather than transcriptional control. For practitioners selecting between intra-articular corticosteroids, this work implies that choice can reasonably rest on factors such as cost, local availability, and individual horse response rather than assumed superiority of one agent's molecular mechanism.
Read the full abstract on PubMed
Practical Takeaways
- •Both triamcinolone acetonide and methylprednisolone acetate show similar anti-inflammatory effects on cartilage at the molecular level, so choice between them may depend on factors other than direct chondroprotection
- •These corticosteroids appear to work partly by reducing matrix-degrading enzyme activity (MMP13) and inflammatory mediators (COX2), supporting their use in joint injections for osteoarthritis
- •The similar efficacy of both drugs at inhibiting cartilage catabolism suggests clinical differences may result from pharmacokinetic properties rather than inherent biological activity on chondrocytes
Key Findings
- •Both triamcinolone acetonide and methylprednisolone acetate significantly inhibited IL-1β-induced MMP13 expression at 6 hours (MPA at 10⁻⁷ M and TA at 10⁻⁶ M)
- •Both corticosteroids significantly suppressed COX2 upregulation induced by IL-1β stimulation
- •TIMP2 expression, which was reduced by IL-1β, was significantly restored by both MPA and TA treatment
- •No significant differences in gene expression effects were observed between MPA and TA, suggesting posttranslational mechanisms account for any clinical differences